We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
2201
Wave Life Sciences
WVE
$1.03B
$113K ﹤0.01%
10,858
– –
MCBC
2202
DELISTED
Macatawa Bank Corp
MCBC
$113K ﹤0.01%
14,416
– –
LCI
2203
DELISTED
Lannett Company, Inc.
LCI
$112K ﹤0.01%
3,860
– –
PRTK
2204
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$112K ﹤0.01%
+21,473
New +$95.4K
VLGEA icon
2205
Village Super Market
VLGEA
$627M
$111K ﹤0.01%
4,017
– –
OSBC icon
2206
Old Second Bancorp
OSBC
$1.31B
$111K ﹤0.01%
14,296
– –
CNBKA
2207
DELISTED
Century Bancorp Inc/Mass
CNBKA
$111K ﹤0.01%
1,431
– –
MRNS
2208
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$111K ﹤0.01%
+10,904
New +$100K
AMC icon
2209
AMC Entertainment Holdings
AMC
$2.26B
$111K ﹤0.01%
2,580
– –
GTT
2210
DELISTED
GTT Communications, Inc.
GTT
$111K ﹤0.01%
13,560
– –
BSRR icon
2211
Sierra Bancorp
BSRR
$528M
$110K ﹤0.01%
5,841
– –
RUTH
2212
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$110K ﹤0.01%
+13,490
New +$118K
TRUE
2213
DELISTED
TrueCar
TRUE
$110K ﹤0.01%
42,606
– –
ATRO icon
2214
Astronics
ATRO
$4.34B
$110K ﹤0.01%
12,458
– –
ATEC icon
2215
Alphatec Holdings
ATEC
$1.49B
$110K ﹤0.01%
+23,314
New +$103K
VRTV
2216
DELISTED
VERITIV CORPORATION
VRTV
$109K ﹤0.01%
+6,450
New +$76K
CYBE
2217
DELISTED
Cyberoptics Corp
CYBE
$109K ﹤0.01%
+3,390
New +$94.6K
MCRB icon
2218
Seres Therapeutics
MCRB
$47.4M
$109K ﹤0.01%
+1,140
New +$100K
HT
2219
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$108K ﹤0.01%
+18,810
New +$100K
RBBN icon
2220
Ribbon Communications
RBBN
$372M
$108K ﹤0.01%
+27,537
New +$100K
MGI
2221
DELISTED
MoneyGram International, Inc. New
MGI
$108K ﹤0.01%
+33,696
New +$72.8K
AMNB
2222
DELISTED
American National Bankshares Inc
AMNB
$108K ﹤0.01%
4,311
– –
MNK
2223
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$107K ﹤0.01%
+39,950
New +$120K
JYNT icon
2224
The Joint Corp
JYNT
$123M
$107K ﹤0.01%
+6,999
New +$91.7K
PRVL
2225
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$107K ﹤0.01%
7,148
– –
87 88
89
90 91

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.